Posts Tagged: dr. grothey

Updates in GI & Breast Cancers

Posted by & filed under Uncategorized.

This past Thursday, Total Health Conferencing hosted a conference for Updates in GI and Breast Cancers. This educational event gathered oncologists, pharmacists, advanced practitioners, and nurses to focus on the latest advancements in GI cancer and breast cancer care. Thank you to our very own Dr. Axel Grothey and Dr. Gregory Vidal for serving as… Read more »

Gastrointestinal (Digestive) Cancers

Posted by & filed under Uncategorized.

At West Cancer Center & Research Institute, our comprehensive team of specialists are here to provide you with the latest treatments and personalized care plans. We see on average 1,069 new gastrointestinal cancer patients annually for the most common types including colorectal, esophageal, liver, stomach, and pancreatic cancers. Colorectal cancer is ranked third as the... Read more »

Updates in GI Cancers with Dr. Axel Grothey

Posted by & filed under Uncategorized.

Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »

Grothey Published in NEJM for Colorectal Cancer Care

Posted by & filed under Uncategorized.

Axel Grothey, MD   The New England Journal of Medicine (NEJM) has recently published an editorial entitled “Pembrolizumab as first-line therapy in mismatch repair-deficient advanced colorectal cancer: A new standard of care” written by West Cancer Center’s GI Medical Oncology Lead and GI Oncology Clinical Research Director, Dr. Axel Grothey.   Click the link below… Read more »